Gambaran Umum
Chugai Pharmaceutical Co., Ltd., based in Tokyo, Japan, is a prominent player in the pharmaceutical industry. The company primarily engages in the research, development, manufacturing, sale, import, and export of pharmaceuticals. Chugai's key projects revolve around oncology, renal disease, and bone and joint diseases. It is known for its innovative biopharmaceuticals and antibody technologies, including the proprietary antibody engineering technology 'Recycling Antibody.' The firm also has a strategic alliance with Roche, a Swiss multinational healthcare company, which allows it to introduce various Roche products into the Japanese market. This partnership has significantly strengthened Chugai's product portfolio and market position.
Skor Kualitas, Nilai, dan Momentum
Kartu ini menunjukkan skor Kualitas, Nilai, dan Momentum untuk perusahaan tersebut.
Laporan Laba Rugi: Pendapatan, Laba Operasional, Laba Bersih
- Nilai revenue untuk Chugai Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 1,196,214.00 MM.
- Nilai operating income untuk Chugai Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 557,148.00 MM.
- Nilai net income untuk Chugai Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 395,444.00 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 1,196,214.00 | 557,148.00 | 395,444.00 |
| 2025-03-31 | 1,222,121.00 | 578,780.00 | 410,150.00 |
| 2024-12-31 | 1,170,611.00 | 542,003.00 | 387,317.00 |
| 2024-09-30 | 1,142,350.00 | 540,178.00 | 386,964.00 |
| 2024-06-30 | 1,084,570.00 | 486,459.00 | 355,041.00 |
| 2024-03-31 | 1,036,076.00 | 440,751.00 | 326,373.00 |
| 2023-12-31 | 1,111,367.00 | 439,174.00 | 325,472.00 |
| 2023-09-30 | 1,276,051.00 | 467,073.00 | 336,745.00 |
| 2023-06-30 | 1,243,437.00 | 457,273.00 | 326,969.00 |
| 2023-03-31 | 1,211,632.00 | 444,598.00 | 316,154.00 |
| 2022-12-31 | 1,259,946.00 | 533,309.00 | 374,429.00 |
| 2022-09-30 | 1,143,716.00 | 522,896.00 | 370,791.00 |
| 2022-06-30 | 1,205,696.00 | 548,165.00 | 389,011.00 |
| 2022-03-31 | 1,191,496.00 | 544,938.00 | 387,359.00 |
| 2021-12-31 | 999,759.00 | 421,897.00 | 302,995.00 |
| 2021-09-30 | 887,919.00 | 356,747.00 | 256,462.00 |
| 2021-06-30 | 809,055.00 | 321,280.00 | 230,577.00 |
| 2021-03-31 | 776,339.00 | 292,785.00 | 210,611.00 |
| 2020-12-31 | 786,946.00 | 301,230.00 | 214,733.00 |
| 2020-09-30 | 753,853.00 | 277,037.00 | 202,590.00 |
| 2020-06-30 | |||
| 2020-03-31 |
Laporan Laba Rugi: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | 235.39 | 235.36 |
| 2024-09-30 | 235.18 | 235.15 |
| 2024-06-30 | 215.79 | 215.76 |
| 2024-03-31 | 198.37 | 198.34 |
| 2023-12-31 | 197.83 | 197.80 |
| 2023-09-30 | 204.69 | 204.65 |
| 2023-06-30 | 198.76 | 198.72 |
| 2023-03-31 | 192.19 | 192.15 |
| 2022-12-31 | 227.64 | 227.57 |
| 2022-09-30 | 225.46 | 225.37 |
| 2022-06-30 | 236.56 | 236.44 |
| 2022-03-31 | 235.58 | 235.44 |
| 2021-12-31 | 184.29 | 184.17 |
| 2021-09-30 | 156.00 | 155.88 |
| 2021-06-30 | 140.26 | 140.16 |
| 2021-03-31 | 128.13 | 128.02 |
| 2020-12-31 | 130.66 | 130.53 |
| 2020-09-30 | 123.30 | 123.16 |
| 2020-06-30 | 116.03 | 115.87 |
| 2020-03-31 | 105.98 | 105.84 |
Arus Kas: Operasi, Investasi, Pendanaan
- Nilai cash from operating activities untuk Chugai Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah 462,121.00 MM.
- Nilai cash from investing activities untuk Chugai Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah -187,944.00 MM.
- Nilai kas dari aktivitas pendanaan untuk Chugai Pharmaceutical Co., Ltd. per 2025 Jun 30 adalah -169,380.00 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | 462,121.00 | -187,944.00 | -169,380.00 |
| 2025-03-31 | 413,364.00 | -282,007.00 | -169,512.00 |
| 2024-12-31 | 447,600.00 | -227,365.00 | -141,006.00 |
| 2024-09-30 | 419,416.00 | -204,818.00 | -141,275.00 |
| 2024-06-30 | 327,068.00 | -165,254.00 | -139,153.00 |
| 2024-03-31 | 383,090.00 | -34,163.00 | -138,922.00 |
| 2023-12-31 | 409,925.00 | -37,290.00 | -139,331.00 |
| 2023-09-30 | 258,712.00 | -64,949.00 | -139,386.00 |
| 2023-06-30 | 252,605.00 | -114,393.00 | -135,981.00 |
| 2023-03-31 | 299,319.00 | -147,383.00 | -136,053.00 |
| 2022-12-31 | 244,112.00 | -145,994.00 | -145,641.00 |
| 2022-09-30 | 366,072.00 | -141,146.00 | -146,266.00 |
| 2022-06-30 | 422,551.00 | -118,859.00 | -133,331.00 |
| 2022-03-31 | 305,626.00 | -106,013.00 | -133,153.00 |
| 2021-12-31 | 279,626.00 | -118,927.00 | -107,408.00 |
| 2021-09-30 | 256,890.00 | -143,000.00 | -106,749.00 |
| 2021-06-30 | 252,664.00 | -167,227.00 | -98,596.00 |
| 2021-03-31 | 246,567.00 | -128,226.00 | -98,655.00 |
| 2020-12-31 | 205,035.00 | -98,312.00 | -99,497.00 |
| 2020-09-30 | 211,422.00 | -107,938.00 | -99,341.00 |
| 2020-06-30 | |||
| 2020-03-31 |
Metrik Penilaian: PE, PriceToBook, PriceToTBV
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | |||
| 2025-03-31 | |||
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | |||
| 2023-06-30 | |||
| 2023-03-31 | |||
| 2022-12-31 | |||
| 2022-09-30 | |||
| 2022-06-30 | |||
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | |||
| 2021-03-31 | |||
| 2020-12-31 | |||
| 2020-09-30 | |||
| 2020-06-30 | |||
| 2020-03-31 |
Metrik Penilaian: EBitToEv, EBit3YrAvgToEv
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | ||
| 2025-03-31 | ||
| 2024-12-31 | ||
| 2024-09-30 | ||
| 2024-06-30 | ||
| 2024-03-31 | ||
| 2023-12-31 | ||
| 2023-09-30 | ||
| 2023-06-30 | ||
| 2023-03-31 | ||
| 2022-12-31 | ||
| 2022-09-30 | ||
| 2022-06-30 | ||
| 2022-03-31 | ||
| 2021-12-31 | ||
| 2021-09-30 | ||
| 2021-06-30 | ||
| 2021-03-31 | ||
| 2020-12-31 | ||
| 2020-09-30 | ||
| 2020-06-30 | ||
| 2020-03-31 |
Efektivitas Manajemen
- roa untuk Chugai Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.20.
- roe untuk Chugai Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.23.
- roic untuk Chugai Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.21.
- croic untuk Chugai Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah -0.02.
- ocroic untuk Chugai Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.22.
| Period End (TTM) | ROA | ROE | ROIC (Tingkat Pengembalian Investasi Modal) | CROIC | OCROIC |
| 2025-06-30 | 0.20 | 0.23 | 0.21 | -0.02 | 0.22 |
| 2025-03-31 | 0.20 | 0.24 | 0.20 | 0.04 | 0.24 |
| 2024-12-31 | 0.20 | 0.24 | 0.21 | 0.04 | 0.23 |
| 2024-09-30 | 0.20 | 0.23 | 0.20 | 0.02 | 0.19 |
| 2024-06-30 | 0.23 | ||||
| 2024-03-31 | 0.23 | ||||
| 2023-12-31 | 0.22 | 0.04 | |||
| 2023-09-30 | 0.22 | 0.00 | |||
| 2023-06-30 | 0.25 | ||||
| 2023-03-31 | 0.25 | ||||
| 2022-12-31 | |||||
| 2022-09-30 | 0.00 | ||||
| 2022-06-30 | 0.00 | 0.00 | |||
| 2022-03-31 | 0.00 | ||||
| 2021-12-31 | 0.31 | 18.89 | |||
| 2021-09-30 | 0.23 | 0.28 | |||
| 2021-06-30 | 0.22 | 0.22 | -0.01 | 0.24 | |
| 2021-03-31 | 0.20 | 0.25 | 0.21 | 0.02 | 0.25 |
| 2020-12-31 | 0.20 | 0.25 | 0.22 | 0.05 | 0.27 |
| 2020-09-30 | 0.20 | 0.25 | 0.22 | 0.01 | 0.23 |
| 2020-06-30 | 0.19 | 0.24 | 0.21 | 0.05 | 0.21 |
| 2020-03-31 | 0.19 | 0.23 | 0.20 | 0.01 | 0.21 |
Gross Margins
- marjin kotor untuk Chugai Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.71.
- marjin bersih untuk Chugai Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.34.
- marjin operasi untuk Chugai Pharmaceutical Co., Ltd. pada 2025 Jun 30 adalah 0.47.
- Margin Kotor
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Margin Keuntungan Bersih
- Margin Bersih (juga dikenal sebagai Margin Keuntungan) adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Bersih. Perhitungannya adalah Pendapatan Bersih / Pendapatan.
- Margin Operasi
- Margin Operasi adalah rasio pendapatan yang tersisa setelah dikurangi Pendapatan Operasi. Perhitungannya adalah Pendapatan Operasi / Pendapatan.
| Period End (TTM) | Margin Kotor | Margin Keuntungan Bersih | Margin Operasi |
| 2025-06-30 | 0.71 | 0.34 | 0.47 |
| 2025-03-31 | 0.71 | 0.33 | 0.46 |
| 2024-12-31 | 0.70 | 0.34 | 0.47 |
| 2024-09-30 | 0.69 | 0.33 | 0.45 |
| 2024-06-30 | |||
| 2024-03-31 | |||
| 2023-12-31 | |||
| 2023-09-30 | 0.26 | 0.37 | |
| 2023-06-30 | 0.26 | 0.37 | |
| 2023-03-31 | 0.24 | 0.41 | |
| 2022-12-31 | |||
| 2022-09-30 | 0.00 | 0.00 | |
| 2022-06-30 | 0.00 | 0.00 | |
| 2022-03-31 | |||
| 2021-12-31 | |||
| 2021-09-30 | |||
| 2021-06-30 | 0.67 | 0.28 | 0.40 |
| 2021-03-31 | 0.66 | 0.27 | 0.38 |
| 2020-12-31 | 0.65 | 0.27 | 0.38 |
| 2020-09-30 | 0.65 | 0.27 | 0.37 |
| 2020-06-30 | 0.63 | 0.26 | 0.35 |
| 2020-03-31 | 0.63 | 0.24 | 0.33 |
Pengenal dan Deskriptor
| Kunci Indeks Pusat (CIK) | 1453934 |
